Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 28 May 2026
- Closes
- 2 Dec 2026, 23:59 UTC
- Value
- USD 1,260,000
- Reference
- RFA-OD-27-008
- Location
- United States
- Sector
- Healthcare & Pharma
At a glance
National Institutes of Health in United States has published a funding call in healthcare & pharma: “Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)”. Submissions close on 2 December 2026, 22 days from today. The stated value is USD 1,260,000. Quote reference RFA-OD-27-008 in any correspondence with the buyer. FreeTender has recorded 458 notices from this buyer since 2023, 371 of them currently open. There are 384 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.
Key requirements
Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.
To bid on Grants.gov (US federal)
Applicants need a UEI from SAM.gov and a Grants.gov account registered to their organisation; allow several weeks for registration.
Details
This NOFO seeks to advance research and training in high-priority areas of child health by stimulating the use of Environmental Influences on Child Health Outcomes (ECHO) Cohort data by postdoctoral fellows from relevant scientific disciplines. This RFA will provide opportunities for fellows to study child health outcomes through the analysis of ECHO's large longitudinal data sets within the NICHD Data and Specimen Hub (DASH) repository. ECHO's DASH dataset integrates de-identified longitudinal data from more than 71,000 participants across the U.S. Prenatal and child exposure data include physical, chemical, social, behavioral, and biological factors. ECHO's five primary pediatric outcome areas are pre-, peri-, and postnatal outcomes, upper and lower airway, obesity, neurodevelopment, and positive health. Eligibility: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Estimated total programme funding: USD 1260000
Expected number of awards: 8
CFDA number(s): 93.121
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 458 notices from National Institutes of Health, going back to May 2023 — 371 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 384 open Healthcare & Pharma tenders in United States. This one closes in 22 days.
More from this buyer
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)· closes 17 Feb
- NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)· closes 20 Feb
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)· closes 16 Nov
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)· closes 1 Feb
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)· closes 5 Mar
Similar Healthcare & Pharma tenders
- Research Grants Supporting Scientific Discovery, Academic Research and New Studies· closes 18 Jan
- Abbott Architect i1000 Reagents — IN Vitro Diagnostic Substances, Reagents, Test Kits and Sets· closes 13 Nov
- Proposed procurement for NSN 4240014790539 CAP,SUSPENSION· closes 20 Nov
- VA Boise, Idaho Medical Center Lab - New Blood Reagents Requirement· closes 19 Nov
- RRC Services located within the city limits of the following cities within San Bernardino County, CA: San Bernardino, Fontana, Rancho Cucamonga, Bloomington, Colton, Grand Terrace, Highland, Loma Linda, and Redlands· closes 11 Jan
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Поставка лекарственного препарата Амикацин, раствор для инфузий и внутримышечного введения и/или раствор для внутривенного и внутримышечного введения, 250 мг/мл, 2 мл и/или порошок для приготовления раствора для внутривенного и внутримышечного введения и/или лиофилизат для приготовления раствора для внутривенного и внутримышечного введения, 500 мг в рамках реализации постановления Правительства РоФЕДЕРАЛЬНОЕ КАЗЕННОЕ УЧРЕЖДЕНИЕ "ФЕДЕРАЛЬНЫЙ ЦЕНТР ПЛАНИРОВАНИЯ И ОРГАНИЗАЦИИ ЛЕКАРСТВЕННОГО ОБЕСПЕЧЕНИЯ ГРАЖДАН" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ · Russia
- Поставка лекарственного препарата Моксифлоксацин, таблетки, покрытые пленочной оболочкой, 400 мг в рамках реализации постановления Правительства Российской Федерации от 28.12.2016 № 1512 «Об утверждении Положения об организации обеспечения лиц, инфицированных вирусом иммунодефицита человека, в том числе в сочетании с вирусами гепатитов В и С, антивирусными лекарственными препаратами для медицинскоФЕДЕРАЛЬНОЕ КАЗЕННОЕ УЧРЕЖДЕНИЕ "ФЕДЕРАЛЬНЫЙ ЦЕНТР ПЛАНИРОВАНИЯ И ОРГАНИЗАЦИИ ЛЕКАРСТВЕННОГО ОБЕСПЕЧЕНИЯ ГРАЖДАН" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ · Russia
- Поставка расходных материалов для ЦКДЛМИНИСТЕРСТВО ИМУЩЕСТВЕННЫХ И ЗЕМЕЛЬНЫХ ОТНОШЕНИЙ ВЛАДИМИРСКОЙ ОБЛАСТИ · Russia
- Поставка реагентов для автоматического биохимического анализатора BS-240ProГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ ПЕРМСКОГО КРАЯ "КУНГУРСКАЯ БОЛЬНИЦА" · Russia
- Поставка канюлей для искусственного кровообращения артериальнойФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "НАЦИОНАЛЬНЫЙ МЕДИЦИНСКИЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР ИМЕНИ В.А. АЛМАЗОВА" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →